Latex and Rubber-Additive Testing in 98 Turkish Healthcare Workers
Doctor’s Notes · Life in Motion · Evidence Review
Editorial disclosure: The featured image is an AI-created illustration of a fictional work or daily-life scene. It is not a patient, diagnosis, before-and-after image or Dr. Arsy #003 treatment result.
Reader question: How different were glove symptoms, latex prick tests and rubber-additive patch tests?
Study snapshot
| Study element | Reported detail |
|---|---|
| Population | 98 healthcare workers, including 71 nurses, evaluated for glove-related symptoms. |
| Design | Questionnaire, latex skin-prick testing, food-allergen prick testing and patch testing to rubber additives, additional haptens and glove pieces. |
| Comparator | Self-reported immediate or eczema symptoms versus objective prick- and patch-test positivity. |
| Timepoint | Single clinical evaluation. |
| Key result | 84/98 reported immediate-type mucocutaneous symptoms, but 9/98 had latex skin-prick positivity. 80/98 reported glove-related hand eczema symptoms, while 17.3% had patch-test positivity to rubber additives or glove pieces. |
| Funding/conflict context | The indexed abstract does not state funding or conflicts. It did not test a moisturizer. |
What was actually measured?
84/98 reported immediate-type mucocutaneous symptoms, but 9/98 had latex skin-prick positivity. 80/98 reported glove-related hand eczema symptoms, while 17.3% had patch-test positivity to rubber additives or glove pieces.
The study shows why symptom history, immediate hypersensitivity testing and delayed contact-allergy testing cannot be treated as interchangeable.
The denominator defines the scope. A patch-test clinic, selected case series, compensation registry, online questionnaire, workplace cohort and general-population survey answer different questions. A percentage from one cannot be silently transferred to the others.
What the result does not prove
Small selected sample, high pretest symptom burden, no unexposed group and possible referral bias limit prevalence estimates for all healthcare workers.
Association, timing and biological plausibility can strengthen an occupational interpretation, but observational evidence cannot automatically establish individual causation. Referral patterns, reporting practices, task mix, protective equipment, nonwork exposures and access to care may all change an estimate.
A PubMed record is a bibliographic source. PubMed indexing is not NIH endorsement of the authors' conclusions, this interpretation or any product.
Exposure detail matters more than the job label
Workers with the same title can handle different materials for different durations. Useful documentation identifies the exact product or process, the route of contact, glove or PPE material, wetness, friction, heat, dust, splash potential, frequency and how symptoms change away from the task.
A symptom survey can identify a pattern, a clinical examination can refine the differential diagnosis, and patch testing can identify delayed sensitization. None of those steps alone proves that a workplace material caused an individual condition. Clinical relevance still requires a credible exposure and time course.
Questions worth recording
- Which task, product, glove, tool, metal, resin, cleanser, food, plant, dust or surface came before symptoms?
- Where did the change begin, and did it improve on days away or after a process or PPE change?
- How often were hands wet, washed, disinfected, occluded, rubbed, heated or exposed to cold?
- Were labels, ingredient information and safety-data sheets reviewed with occupational health?
- Did the problem affect dexterity, sleep, pace, attendance, work quality or safety?
Prevention comes before cosmetic care
Substitution, closed systems, local exhaust, splash control, safer cleaning methods, training and correctly selected protective equipment address exposure at its source. Gloves are not automatically protective: material, fit, breakthrough time, sweating, reuse and rubber accelerators all matter.
Do not deliberately place workplace products on skin to test a theory. Persistent, recurrent or spreading symptoms, drainage, fever, breathing symptoms, severe pain, rapidly worsening redness or major loss of function warrant professional evaluation.
Primary research and guidance
- Primary research record: PubMed PMID 37557117
- NIOSH: occupational skin exposure
- NIAMS: atopic dermatitis
- American Academy of Dermatology: eczema skin care
Where Dr. Arsy #003 fits
Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. This study did not test #003. Its findings do not show that #003 treats, cures or prevents eczema, relieves pain or itch, neutralizes workplace chemicals, is appropriate for every person, or provides pediatric or 24-hour efficacy.
Continue the evidence series
- One-Year Work Retention After Prevention in 1,486 Patients
- Illness Beliefs in 248 Workers With Occupational Hand Eczema
- Hand and Face Skin Reports From 434 UAE Dental Professionals
- Hand-Eczema Signs Reported by 863 Northern Italian Hospital Workers
Evidence note: This educational article separates reported findings from interpretation. It is not a diagnosis, treatment recommendation or workplace-safety determination.